Shares of Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) ended Thursday session in red amid volatile trading. The shares closed down -0.25 points or -0.49% at $51.04 with 4.83 million shares getting traded. Post opening the session at $51.35, the shares hit an intraday low of $50.93 and an intraday high of $51.79 and the price vacillated in this range throughout the day. The company has a market cap of $51.67 billion and the numbers of outstanding shares have been calculated to be 1.01 billion shares.
Teva Pharmaceutical Industries Ltd (ADR) (TEVA) on September 7, 2016 announced that data on COPAXONE® (glatiramer acetate injection), a product for relapsing forms of multiple sclerosis (MS), and laquinimod, an investigational therapy for relapsing and primary progressive forms of MS, will be presented at the 32nd Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in London, September 14-17, 2016.
“For more than 30 years, Teva has been dedicated to addressing the many unmet needs in MS by investigating new compounds and providing safe and effective treatment options,” said Michael Hayden, M.D., Ph.D., President of Global R&D and Chief Scientific Officer at Teva. “We look forward to showcasing new data from our MS portfolio at this year’s ECTRIMS.”
In addition to the data being presented, Teva will also host a Satellite Symposium, “Multiple Disciplines, Common Goals: Just a Minute! Challenge the Expert Panel,” on September 15, 2016 from 6:00 – 7:00 p.m. GMT.
Shares of Inovio Pharmaceuticals Inc (NASDAQ:INO) ended Thursday session in red amid volatile trading. The shares closed down -0.11 points or -1.22% at $8.94 with 672,897.00 shares getting traded. Post opening the session at $9.05, the shares hit an intraday low of $8.87 and an intraday high of $9.06 and the price vacillated in this range throughout the day. The company has a market cap of $661.18 million and the numbers of outstanding shares have been calculated to be 73.55 million shares.
Inovio Pharmaceuticals Inc (INO) announced that it will present a corporate overview at the following upcoming conferences:
23rd Annual Newsmakers in the Biotech Industry
Millennium Broadway Hotel, New York, Friday, September 9th, 11:00 am ET
Rodman & Renshaw 18th Annual Global Investment Conference
Lotte New York Palace Hotel, New York, Monday, September 12th, 2:35 pm ET
A live and archived version of the Rodman & Renshaw presentation delivered by Inovio’s CEO, Dr. J. Joseph Kim, will be available through the “Webcast” tab on Inovio’s home page at www.inovio.com as well as at the following URL: http://wsw.com/webcast/rrshq26/ino.